We apologize your item could not be found. Not all items are listed on our website. Please contact your account manager for details regarding your searched item.
Material number (eg: xxxxxxxxxxx) no space or hyphen needed.
No Results Found
With the explosive growth in social media, mobile devices, cloud computing and access to data both internal and external to West (now referred to as Big Data), West IT has been working to ensure that we are able to leverage these transformational trends. In 2012, we updated our IT strategy to allow us to be part of the revolution while making it feel more like an evolution. The initial phase began with investments in cloud technologies – both private and public – to drive down IT operating costs and to enable us to take advantage of software enhancements made by our strategic partners.
West IT also recognizes the changing world of work that mobility and social media have introduced. We are constantly striving to enable West to be more connected and productive, and we continue to simplify the ways we find and share information. This also means enabling devices and mobile experiences our colleagues will value and love. At the same time, West IT continues to be mindful of our security, manageability and compliance responsibilities when we introduce new technologies. Since more and more data is residing on smartphones and tablets, we are educating our employees on the impact of data to the business.
As good stewards, we all must protect company data. The number one way for data to get outside of the enterprise is through mobile devices and applications. That said, as mobile devices continue to propagate into every part of our lives, the demand for applications and for access to systems from these devices and through the cloud offer the best opportunity for IT to enable West to innovate. Whether through developing and deploying mobile apps to access existing data or enabling West to serve customers and partners better, mobile devices provide fertile ground for innovation so that West can be by your side in the connected world.
In 2018, CNDA (National Drug Administration of China) issued Technical Guidance of Drug Compatibility with Rubber Elastomer Closures. This clearly demonstrates a focus on administrative guidelines for the safe and effective use of rubber components, which along with plastic and glass, are the most widely used materials in the packaging of parenteral drug products.
Diane Paskiet, Director Scientific Affairs, will provide an update on the PQRI-PODP working group at the Smithers Rapra Extractables and Leachables conference in Barcelona, Spain on November 10-12, 2014.
Coring and fragmentation are two typical events that can occur when a needle is pierced through a vial closure to withdraw drugs from the vial or expel drugs into the vial.
In 2011, the US FDA issued an advisory regarding the potential formation of glass lamellae in vials containing injectable drugs. This was in response to several drug recalls in 2010-11. The number of glass-related drug recalls has since declined greatly. This no doubt is due to key actions taken by pharmaceutical manufacturers before the drug goes to market, even during the development phases.
Administration of cell therapy drug products requires the delivery of cell suspensions without loss of function or viability. Cells must be transferred aseptically from their original container closure system to the administration system by infusion. However, the common transfer practice of using needles and syringes to pierce vial stoppers to retrieve contents poses a risk, namely needle-stick injury to clinicians.
English
Chinese
